FDA Approved: INREBIC — Original Application (Celgene Corporation)

View source ↗

Summary

FDA approved INREBIC (fedratinib hydrochloride) from Celgene as an original application for adults with myelofibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• INREBIC (fedratinib hydrochloride)

Snippet

ORIG AP for INREBIC (FEDRATINIB HYDROCHLORIDE)